$AMMJ
American Cannabis Company, Inc. Stock $ammj

$ammj Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000190359624000282 Filed on May 08, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue		$281.2K	$2.476M
YoY Change		-97.52%	-86.83%
Cost Of Revenue		$160.9K	$1.434M
YoY Change		-98.37%	-91.19%
Gross Profit		$120.3K	$10.14M
YoY Change		-91.82%	299.73%
Gross Profit Margin		42.77%	409.58%
Selling, General & Admin		$1.967M	$1.805M
YoY Change		117.35%	-41.0%
% of Gross Profit		1635.45%	17.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$61.78K	$56.45K
YoY Change		-45.89%	-75.19%
% of Gross Profit		51.38%	0.56%
Operating Expenses		$1.967M	$4.893M
YoY Change		117.37%	55.69%
Operating Profit		-$1.847M	-$3.851M
YoY Change		-426.82%	535.86%
Interest Expense		-$20.56K	$113.6K
YoY Change		-81.33%	45.49%
% of Operating Profit
Other Income/Expense, Net		$117.1K	$190.7K
YoY Change		4529.64%	-792.68%
Pretax Income		-$3.082M	-$3.660M
YoY Change		-773.77%	478.09%
Income Tax
% Of Pretax Income
Net Earnings		-$3.082M	-$3.660M
YoY Change		-773.77%	478.09%
Net Earnings / Revenue		-1096.13%	-147.82%
Basic Earnings Per Share
Diluted Earnings Per Share		-$0.02	-$0.03
COMMON SHARES
Basic Shares Outstanding	185.8M shares	171.4M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.09K	$21.09K
YoY Change	-83.41%	-83.41%
Cash & Equivalents	$21.09K	$21.09K
Short-Term Investments	$0.00	$0.00
Other Short-Term Assets	$58.76K	$58.76K
YoY Change	-20.52%	-20.52%
Inventory	$586.2K	$586.2K
Prepaid Expenses
Receivables	$234.3K	$234.3K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$900.4K	$900.4K
YoY Change	-12.0%	-12.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$410.3K	$884.8K
YoY Change	-4.05%	-14.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.000K	$6.000K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$1.929M	$1.929M
YoY Change	-46.32%	-46.32%
TOTAL ASSETS
Total Short-Term Assets	$900.4K	$900.4K
Total Long-Term Assets	$1.929M	$1.929M
Total Assets	$2.829M	$2.829M
YoY Change	-38.71%	-38.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.011M	$1.323M
YoY Change	48.82%	56.12%
Accrued Expenses	$135.2K	$355.1K
YoY Change	245.55%	43.92%
Deferred Revenue
YoY Change
Short-Term Debt	$300.0K	$300.0K
YoY Change	-45.45%	-45.45%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.168M	$2.168M
YoY Change	3.25%	3.25%
LONG-TERM LIABILITIES
Long-Term Debt	$385.4K	$385.4K
YoY Change	156.95%	156.95%
Other Long-Term Liabilities	$274.6K	$274.6K
YoY Change	-44.79%	-44.79%
Total Long-Term Liabilities	$660.0K	$660.0K
YoY Change	7.68%	1.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.168M	$2.168M
Total Long-Term Liabilities	$660.0K	$660.0K
Total Liabilities	$2.828M	$2.828M
YoY Change	2.95%	2.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.74M
YoY Change	36.31%
Common Stock	$1.714K
YoY Change	85.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.550K	$1.550K
YoY Change
Total Liabilities & Shareholders Equity	$2.829M	$2.829M
YoY Change	-38.71%	-38.71%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$3.082M	-$3.660M
YoY Change	-773.77%	478.09%
Depreciation, Depletion And Amortization	$61.78K	$56.45K
YoY Change	-45.89%	-75.19%
Cash From Operating Activities	$287.2K	-$42.97K
YoY Change	-207.27%	-78.4%
INVESTING ACTIVITIES
Capital Expenditures	-$900.00	$39.10K
YoY Change	-92.27%	-62.28%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$900.00	-$39.10K
YoY Change	-92.27%	-62.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-274.6K	$14.57K
YoY Change	-250.75%	-105.82%
NET CHANGE
Cash From Operating Activities	287.2K	-$42.97K
Cash From Investing Activities	900.0	-$39.10K
Cash From Financing Activities	-274.6K	$14.57K
Net Change In Cash	13.54K	-$96.46K
YoY Change	-118.3%	-82.55%
FREE CASH FLOW
Cash From Operating Activities	$287.2K	-$42.97K
Capital Expenditures	-$900.00	$39.10K
Free Cash Flow	$288.1K	-$82.08K
YoY Change	-212.5%	-72.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000945617
CY2023Q4	ammj	Deposit Assets Current DepositAssetsCurrent		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q4	ammj	Litigation Settlement LitigationSettlement		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	us-gaap	Gross Profit GrossProfit	10141882	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment		usd
CY2023	ammj	Debt Forgiveness DebtForgiveness		usd
CY2022	ammj	Debt Forgiveness DebtForgiveness		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense		usd
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense		usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment		usd
CY2023	ammj	Debt Instrument Decrease Forgivenes DebtInstrumentDecreaseForgivenes		usd
CY2022	ammj	Debt Instrument Decrease Forgivenes DebtInstrumentDecreaseForgivenes		usd
CY2023	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023	us-gaap	Interest Paid InterestPaid		usd
CY2022	us-gaap	Interest Paid InterestPaid		usd
CY2023	ammj	Initial Recognition Of Lease InitialRecognitionOfLease		usd
CY2022	ammj	Stock Issued From Stock Payable StockIssuedFromStockPayable		usd
CY2023	ammj	Total Income Tax Benefit TotalIncomeTaxBenefit		usd
CY2022	ammj	Total Income Tax Benefit TotalIncomeTaxBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic		usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther		usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q4	ammj	Less Amount Representing Interest LessAmountRepresentingInterest		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-26108
CY2023	dei	Entity Registrant Name EntityRegistrantName	AMERICAN CANNABIS COMPANY, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1116625
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1004 Tejon Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Colorado Springs
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80903
CY2023	dei	City Area Code CityAreaCode	303
CY2023	dei	Local Phone Number LocalPhoneNumber	974-4770
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	1671477	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	185800915	shares
CY2023	dei	Auditor Name AuditorName	Hudgens CPA, PLLC
CY2023	dei	Auditor Firm AuditorFirmId	6849
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21085	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117547	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	234330	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	469111	usd
CY2022Q4	ammj	Deposit Assets Current DepositAssetsCurrent	9595	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	586206	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	352971	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	58757	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	73933	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	900378	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1023157	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	410344	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	427669	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1037909	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1223242	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1332113	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	474472	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	604020	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	6000	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	6000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	1518381	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	3165375	usd
CY2023Q4	us-gaap	Assets Assets	2829083	usd
CY2022Q4	us-gaap	Assets Assets	4616201	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1010698	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	679163	usd
CY2023Q4	ammj	Advance From Client AdvanceFromClient	162414	usd
CY2022Q4	ammj	Advance From Client AdvanceFromClient	280075	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	467495	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	233348	usd
CY2023Q4	ammj	Stock Payable StockPayable	17021	usd
CY2022Q4	ammj	Stock Payable StockPayable	74343	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	199891	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	181661	usd
CY2023Q4	ammj	Litigation Settlement Current LitigationSettlementCurrent	10000	usd
CY2022Q4	ammj	Litigation Settlement Current LitigationSettlementCurrent	100000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	300000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	550000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2167519	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2099220	usd
CY2022Q4	ammj	Litigation Settlement LitigationSettlement	75000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	274581	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	422359	usd
CY2023Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	385433	usd
CY2022Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	150000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	660014	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	612960	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2827533	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2712180	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	171402938	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	171402938	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	92152938	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1714	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	922	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13740961	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13741125	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1550	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2829083	usd
CY2023	ammj	Consulting And Advisory Revenues ConsultingAndAdvisoryRevenues	695089	usd
CY2023	ammj	Equipment Supplies Revenues EquipmentSuppliesRevenues	1024191	usd
CY2023	ammj	Cannabis Products CannabisProducts	756905	usd
CY2023	us-gaap	Revenues Revenues	2476185	usd
CY2023	ammj	Cost Of Consulting And Advisory CostOfConsultingAndAdvisory	115085	usd
CY2022	ammj	Cost Of Consulting And Advisory CostOfConsultingAndAdvisory	61246	usd
CY2023	ammj	Cost Of Equipment Supplies CostOfEquipmentSupplies	724921	usd
CY2023	ammj	Cost Of Cannabis Product CostOfCannabisProduct	594296	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1434302	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1650498	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	154470	usd
CY2023	ammj	Bad Debt Expense BadDebtExpense	20933	usd
CY2022	ammj	Bad Debt Expense BadDebtExpense	5438	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	1332113	usd
CY2023	ammj	Stock Based Compensation Expense StockBasedCompensationExpense	1735021	usd
CY2022	ammj	Stock Based Compensation Expense StockBasedCompensationExpense	78342	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	4893035	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	3142870	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3851152	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-605656	usd
CY2023	us-gaap	Interest Expense InterestExpense	113609	usd
CY2022	us-gaap	Interest Expense InterestExpense	78086	usd
CY2023	us-gaap	Other Income OtherIncome	304345	usd
CY2022	us-gaap	Other Income OtherIncome	50550	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	190736	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	27537	usd
CY2023	ammj	Net Income Loss1 NetIncomeLoss1	-3660416	usd
CY2022	ammj	Net Income Loss1 NetIncomeLoss1	-633193	usd
CY2023	ammj	Netlosses Netlosses	-3660416	usd
CY2022	ammj	Netlosses Netlosses	-633193	usd
CY2023	ammj	Basic Net Loss Per Common Share BasicNetLossPerCommonShare	-0.03
CY2022	ammj	Basic Net Loss Per Common Share BasicNetLossPerCommonShare	-0.01
CY2023	ammj	Basic And Diluted Weighted Average Common Shares Outstanding BasicAndDilutedWeightedAverageCommonSharesOutstanding	109911842	shares
CY2022	ammj	Basic And Diluted Weighted Average Common Shares Outstanding BasicAndDilutedWeightedAverageCommonSharesOutstanding	85727938	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3660416	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-633192	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	63344	usd
CY2023	ammj	Depreciation Expense DepreciationExpense	241781	usd
CY2022	ammj	Depreciation Expense DepreciationExpense	227533	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1735022	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	266207	usd
CY2023	ammj	Operating Lease Expense1 OperatingLeaseExpense1	129548	usd
CY2022	ammj	Operating Lease Expense1 OperatingLeaseExpense1	192432	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	1332113	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-234781	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	522139	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	233235	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	74363	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-24771	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	29282	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	331535	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	436484	usd
CY2023	ammj	Advances From Clients AdvancesFromClients	118291	usd
CY2022	ammj	Advances From Clients AdvancesFromClients	-168813	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	234147	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	71630	usd
CY2023	ammj	Litigation Settlement Liability LitigationSettlementLiability	-165000	usd
CY2023	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-129548	usd
CY2022	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-192432	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-42972	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-198965	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39103	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14567	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-250236	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-96462	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-552876	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117547	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	103675	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39103	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-103675	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	250000	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	550000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	235433	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	150000	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	149764	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	670423	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21085	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117547	usd
CY2022	ammj	Initial Recognition Of Lease InitialRecognitionOfLease	700300	usd
CY2023	ammj	Stock Issued From Stock Payable StockIssuedFromStockPayable	74344	usd
CY2021Q4	ammj	Stockholders Equity1 StockholdersEquity1	2118981	usd
CY2022	ammj	Stock Issued During Period Value Employee Benefit Plan2 StockIssuedDuringPeriodValueEmployeeBenefitPlan2	46226	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	169979	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	117628	usd
CY2022	ammj	Stock Issued For Consultant StockIssuedForConsultant	50000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-633192	usd
CY2022Q4	ammj	Stockholders Equity1 StockholdersEquity1	1869622	usd
CY2022Q4	ammj	Stockholders Equity1 StockholdersEquity1	1869622	usd
CY2023	ammj	Stock Issued During Period Value Employee Benefit Plan1 StockIssuedDuringPeriodValueEmployeeBenefitPlan1	1792344	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-3660416	usd
CY2023Q4	ammj	Stockholders Equity1 StockholdersEquity1	1550	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zufWW8dffh63" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_z1fZ6ff74Yy1">Use of Estimates in Financial Reporting</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in preparing the Company's consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2023	ammj	Bad Debt Expenses BadDebtExpenses	0	usd
CY2022	ammj	Bad Debt Expenses BadDebtExpenses	20933	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zXIkRjtlVZDb" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zpkzNToNABsj">Significant Clients and Customers</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2023, 11 customers accounted for 84.13% of the Company's total revenues from its retail and wholesale sales, consulting, soil, and products revenue lines for the period.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2023, 3 customers accounted for 98.21 % of accounts receivable, net, consisting of customers of our retail and wholesale sales, consulting services, and soil and products revenue streams.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-223454	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	154470	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	225950	usd
CY2023	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	63916	usd
CY2022	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	428083	usd
CY2023	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	159539	usd
CY2022	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	187711	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-615794	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1163725	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1152244	usd
CY2023Q4	ammj	Allowance For Doubtful Accounts AllowanceForDoubtfulAccounts	1040	usd
CY2022Q4	ammj	Allowance For Doubtful Accounts AllowanceForDoubtfulAccounts	1040	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1164765	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1153284	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1164765	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1153284	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	75300	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	38464	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	444532	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	206306	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	234330	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	469111	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4071	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4071	usd
CY2023Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	230259	usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	465040	usd
CY2023	ammj	Allowances For Bad Debt Expenses AllowancesForBadDebtExpenses	20933	usd
CY2022	ammj	Allowances For Bad Debt Expenses AllowancesForBadDebtExpenses	5438	usd
CY2022	ammj	Advance From Clients AdvanceFromClients	111892	usd
CY2022	ammj	Additional Deposits Received AdditionalDepositsReceived	691769	usd
CY2022	ammj	Less Deposits Recognized As Revenue LessDepositsRecognizedAsRevenue	-522663	usd
CY2022	ammj	Advance From Clients Ending AdvanceFromClientsEnding	280705	usd
CY2023	ammj	Advance From Clients Current Year AdvanceFromClientsCurrentYear	280705	usd
CY2023	ammj	Additional Deposits Received AdditionalDepositsReceived	659790	usd
CY2023	ammj	Less Deposits Recognized As Revenue LessDepositsRecognizedAsRevenue	-778081	usd
CY2022	ammj	Advance From Clients Ending Current Year AdvanceFromClientsEndingCurrentYear	162414	usd
CY2023Q4	ammj	Finished Goods Soil FinishedGoodsSoil	0	usd
CY2022Q4	ammj	Finished Goods Soil FinishedGoodsSoil	66557	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	66374	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	41464	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	586206	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	352971	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	580422	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	541319	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	170099	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	113650	usd
CY2023Q4	ammj	Property Plant And Equipment Net1 PropertyPlantAndEquipmentNet1	410324	usd
CY2022Q4	ammj	Property Plant And Equipment Net1 PropertyPlantAndEquipmentNet1	427669	usd
CY2023	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	39103	usd
CY2022	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	103675	usd
CY2023	us-gaap	Depreciation Depreciation	56448	usd
CY2022	us-gaap	Depreciation Depreciation	57731	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1478464	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	440555	usd
CY2023Q4	ammj	Finite Lived Intangible Assets Net1 FiniteLivedIntangibleAssetsNet1	1037909	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	186000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	186000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	186000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	186000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	186000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	145997	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	54000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	463781	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	135213	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	39130	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	11711	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	22029	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	8319	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3931	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	312252	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	168258	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	467495	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	233348	usd
CY2022Q4	ammj	Stock Payables StockPayables	74344	usd
CY2023	ammj	Shares Issued1 SharesIssued1	-74344	shares
CY2023	ammj	Accrued Stock Compensation AccruedStockCompensation	17021	usd
CY2023Q4	ammj	Stock Payables StockPayables	17021	usd
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	474472	usd
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	474472	usd
CY2023Q4	ammj	Present Value Of Future Minimum Lease Payments PresentValueOfFutureMinimumLeasePayments	474472	usd
CY2023Q4	ammj	Current Obligations Under Leases CurrentObligationsUnderLeases	-199891	usd
CY2023Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	274581	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	474472	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	474472	usd

Files In Submission

Name	View Source	Status
0001903596-24-000282-index-headers.html	Edgar Link	pending
0001903596-24-000282-index.html	Edgar Link	pending
0001903596-24-000282.txt	Edgar Link	pending
0001903596-24-000282-xbrl.zip	Edgar Link	pending
ammj-20231231.xsd	Edgar Link	pending
ammj_10k.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
ammj-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ammj_10k_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ammj-20231231_cal.xml	Edgar Link	unprocessable
ammj-20231231_lab.xml	Edgar Link	unprocessable
ammj-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMMJ
American Cannabis Company, Inc. Stock $ammj

2024 Q2 Form 10-K Financial Statement

#000190359624000282 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMMJ American Cannabis Company, Inc. Stock $ammj

2024 Q2 Form 10-K Financial Statement

#000190359624000282 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMMJ
American Cannabis Company, Inc. Stock $ammj